Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuya Pal

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2Mario E Beiner, Barry Rosen, Anthony Fyles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/EthnicityJaleesa Moore, Fei Wang, Tuya Pal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 14, 2019
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Doreen Agnese, Mary Daly, et al.
Journal of Health Care for the Poor and Underserved|February 14, 2022
The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of AccomplishmentsTuya Pal, Sarah V Suiter, Harold L Moses, et al.
JAMA Oncology|September 20, 2019
Overall Mortality After Diagnosis of Breast Cancer in Men vs WomenFei Wang, Xiang Shu, Ingrid Meszoely, et al.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
Psycho-Oncology|April 24, 2020
Patterns and covariates of benefit finding in young Black breast cancer survivors: A longitudinal, observational studyClaire C Conley, Brent J Small, Juliette Christie, et al.
Cancer Medicine|August 21, 2023
Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trialKelly A Metcalfe, Tuya Pal, Steven A Narod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2019
Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast CancerFei Wang, Sonya Reid, Wei Zheng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Marc Tischkowitz, Judith Balmaña, William D Foulkes, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2Mario E Beiner, Barry Rosen, Anthony Fyles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/EthnicityJaleesa Moore, Fei Wang, Tuya Pal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 14, 2019
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Doreen Agnese, Mary Daly, et al.
Journal of Health Care for the Poor and Underserved|February 14, 2022
The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of AccomplishmentsTuya Pal, Sarah V Suiter, Harold L Moses, et al.
JAMA Oncology|September 20, 2019
Overall Mortality After Diagnosis of Breast Cancer in Men vs WomenFei Wang, Xiang Shu, Ingrid Meszoely, et al.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
Psycho-Oncology|April 24, 2020
Patterns and covariates of benefit finding in young Black breast cancer survivors: A longitudinal, observational studyClaire C Conley, Brent J Small, Juliette Christie, et al.
Cancer Medicine|August 21, 2023
Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trialKelly A Metcalfe, Tuya Pal, Steven A Narod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2019
Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast CancerFei Wang, Sonya Reid, Wei Zheng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Marc Tischkowitz, Judith Balmaña, William D Foulkes, et al.
Pageof 18